Neurology is the branch of medicine devoted to diagnosing and treating disorders of the nervous system, which includes the brain, spinal cord, peripheral nerves, and muscles. A neurologist is a physician who has completed additional specialty training to manage conditions ranging from stroke and epilepsy to Parkinson’s disease and migraine. The field’s reach is broader than many people expect: a 2021 systematic analysis found that 37 neurological conditions collectively affect roughly 3.4 billion people worldwide, making nervous system disorders the leading group cause of disability globally.
How Neurology Became Its Own Specialty
For most of modern medical history, neurology did not stand on its own. It grew out of internal medicine and psychiatry, and the two sibling fields of neurology and psychiatry stayed tightly connected in both teaching and clinical practice well into the twentieth century.1PubMed. The founding of neurology as a specialty: The American situation in context That shared lineage still matters today. Many neurological conditions produce psychiatric symptoms, and some psychiatric disorders turn out to have detectable brain pathology. The overlap means neurologists often work alongside psychiatrists, particularly when dealing with conditions like functional neurological disorder, where symptoms can mimic classic neurological disease yet arise from altered brain function rather than structural damage.2PubMed Central. Functional Neurological Disorder Overlapping Paroxysmal Kinesigenic Dyskinesia Confirmed by Genetic Diagnosis
What a Neurologist Actually Does
A visit to a neurologist usually starts with something surprisingly low-tech: a clinical examination. The neurologist tests reflexes, muscle strength, coordination, sensation, and cranial nerve function using simple bedside tools. The cranial nerve exam alone can reveal problems with vision, facial movement, hearing, swallowing, and tongue control, all of which trace back to specific brain regions.3New England Journal of Medicine. Clinical Examination of the Cranial Nerves That physical exam guides which further tests, if any, are needed.
Beyond the bedside exam, neurologists rely on a toolkit of diagnostic technologies. Brain imaging, chiefly CT and MRI, is the workhorse. CT scans are fast and widely available, making them the go-to in emergencies like suspected stroke. MRI provides finer detail of soft tissue and is better at revealing conditions like multiple sclerosis plaques or small tumors. A review of imaging accuracy across thousands of cases found CT detected brain disorders in about 78% of cases, while MRI detected them in roughly 74%, though the two modalities excel at different things.4PubMed Central. Effectiveness of radiology modalities in diagnosing and characterizing brain disorders Neurologists assess imaging findings by looking at where a lesion sits, how large it is, whether there are multiple lesions, and how the tissue responds to contrast dye.5PubMed. Brain CT and MRI: differential diagnosis of imaging findings When standard scans leave ambiguity, advanced techniques like PET imaging with specialized tracers can help distinguish tumor recurrence from treatment-related changes or separate one type of brain lesion from another.6PubMed. Methionine-PET to differentiate between brain lesions appearing similar on conventional CT/MRI scans
Electrophysiology testing is another key tool. Electromyography, or EMG, records the electrical activity of muscles and nerves to help diagnose conditions affecting the peripheral nervous system. Modern EMG has become increasingly sensitive and is typically combined with nerve conduction studies and other tests to build a full picture of what is happening between the brain and the muscles.7PubMed. The role of electromyography in neurology Electroencephalography, or EEG, records brain wave patterns and is essential for diagnosing epilepsy and monitoring seizure activity.
Lumbar puncture, often called a spinal tap, lets neurologists collect cerebrospinal fluid for analysis. This procedure is critical for diagnosing infections like meningitis, detecting markers of multiple sclerosis, and increasingly for measuring biomarkers of Alzheimer’s disease. However, the procedure itself can temporarily alter the concentrations of certain proteins in the fluid. In primate research, levels of key Alzheimer’s biomarkers spiked dramatically in the days following a lumbar puncture and did not return to baseline for about ten days.8PubMed Central. Lumbar puncture increases Alzheimer’s disease biomarker levels in cerebrospinal fluid of rhesus monkeys That finding highlights the care neurologists must take in timing and interpreting these tests.
Stroke and Vascular Neurology
Stroke is one of the most time-sensitive emergencies a neurologist faces. When a blood clot blocks an artery feeding the brain, brain tissue starts dying within minutes. The classic treatment is intravenous clot-dissolving medication, but a revolution in stroke care over the past decade has come from endovascular thrombectomy, a procedure where a catheter is threaded through the arteries to physically pull the clot out. Randomized trials found that thrombectomy on top of standard clot-dissolving drugs produced overwhelmingly positive results for strokes in the front part of the brain’s circulation within six hours, with fewer than three patients needing treatment for one to benefit. For patients treated in an extended window of six to twenty-four hours who still had salvageable brain tissue on imaging, the results were even stronger, with fewer than two patients needing treatment for one to benefit.9PubMed. Endovascular thrombectomy for acute ischemic stroke
Not every patient receives clot-dissolving medication in time, or some do not respond to it. Research on patients who were ineligible for or failed initial drug treatment found that thrombectomy could still lead to favorable outcomes, with successful reopening of the blocked vessel strongly tied to better recovery and lower mortality.10PubMed. Endovascular thrombectomy for acute ischemic stroke in failed intravenous tissue plasminogen activator versus non-intravenous tissue plasminogen activator patients Stroke care increasingly involves collaboration between neurologists, interventional neuroradiologists, and neurosurgeons, with decisions about treatment for conditions like unruptured brain aneurysms best handled by multidisciplinary teams.11BMJ Journals (Journal of Neurology, Neurosurgery & Psychiatry). Endovascular management of unruptured intracranial aneurysms: the dawn of a multidisciplinary treatment paradigm
Neurodegenerative Diseases
Alzheimer’s disease is the most common neurodegenerative disorder. Its hallmark features, abnormal protein plaques and tangles in the brain, were first described over a century ago and remain central to diagnosis. Researchers now understand that these changes follow a predictable geographic pattern in the brain, with plaques spreading from the outer cortex inward and tangles progressing from deep memory structures outward to the wider cortex.12Neurotherapeutics. Current Approaches to the Neuropathological Assessment of Alzheimer’s Disease and Other Dementias One of the most important realizations of recent decades is that these pathological changes begin decades before any symptoms appear, opening a window for potential early detection and intervention.
Advanced MRI techniques are catching up to what used to be visible only at autopsy. Diffusion MRI can detect microstructural changes in brain tissue that correlate with the severity of both plaque and tangle pathology, and these changes track with cognitive decline measured up to sixteen years before death.13PubMed Central. Gray matter microstructure from in vivo diffusion magnetic resonance imaging reflects post mortem neuropathology severity and clinical progression of Alzheimer’s disease For patients and families, this means diagnosis is moving away from a clinical guess and toward measurable biomarkers, though a cure remains elusive.
Movement Disorders
Parkinson’s disease is the most recognized movement disorder. It results from the death of dopamine-producing neurons in a deep brain region called the substantia nigra. The loss of dopamine triggers a cascade of changes across the brain’s motor circuits, ultimately making movement slow, stiff, and tremor-prone.14PubMed. Functional changes of the basal ganglia circuitry in Parkinson’s disease The core symptoms, rigidity, slow movement, and resting tremor, respond to dopamine replacement therapy, which remains the standard treatment.15PubMed Central. Dopamine Replacement Therapy, Learning and Reward Prediction in Parkinson’s Disease: Implications for Rehabilitation
Dopamine replacement is effective at managing motor symptoms, but it does not slow the underlying neurodegeneration. Over years of treatment, many patients develop complications like involuntary movements or fluctuations in how well the medication works throughout the day. Deep brain stimulation, a surgical procedure where electrodes are implanted in specific brain targets, can help smooth out these fluctuations in selected patients. For other movement disorders like essential tremor, dystonia, and Huntington’s disease, neurologists use different combinations of medication, botulinum toxin injections, and sometimes surgery depending on the specific condition.
Multiple Sclerosis and Neuroimmunology
Multiple sclerosis is an autoimmune condition in which the immune system attacks the insulating coating around nerve fibers in the brain and spinal cord, leading to inflammation, loss of that insulation, and ultimately damage to the nerve fibers themselves.16PubMed Central. Disease Modifying Therapy in Multiple Sclerosis Symptoms vary enormously depending on where in the nervous system the damage occurs: vision problems, numbness, weakness, walking difficulty, and fatigue are all common. Diagnosing MS can be tricky because functional neurological disorder can produce similar symptoms, and the two conditions sometimes coexist in the same person. Over-relying on brain MRI findings alone or on the presence of psychiatric symptoms can lead to misdiagnosis in either direction.17PubMed Central. Functional neurological disorder and multiple sclerosis: a systematic review of misdiagnosis and clinical overlap
A growing number of disease-modifying therapies can reduce the frequency and severity of MS relapses by calming the immune attack. These drugs range from injectable interferons to newer oral medications and potent infusion therapies. The honest limitation is that current treatments are effective at controlling inflammation but have not yet shown the ability to prevent the long-term nerve degeneration that drives accumulating disability.16PubMed Central. Disease Modifying Therapy in Multiple Sclerosis
Epilepsy
Epilepsy involves a gradual shift in the brain toward a state of excessive electrical excitability. At the cellular level, changes in ion channels, neurotransmitter balance, and the connections between neurons push circuits toward synchronized bursts of activity that manifest as seizures.18Journal of Innovations in Medical Research. Epileptogenesis as a Multilevel Process: Cellular, Circuit, and Network Mechanisms Anti-seizure drugs work by targeting several of these mechanisms: some stabilize overexcitable ion channels, others boost the brain’s main inhibitory chemical signals, and still others interfere with the machinery that releases excitatory signals between neurons.19PubMed Central. Mechanisms of Action of Antiseizure Drugs and the Ketogenic Diet The ketogenic diet, a high-fat, very-low-carbohydrate eating plan, is another established option, particularly for children whose seizures do not respond to medication.
For roughly a third of people with epilepsy, medications do not fully control seizures. These individuals may be candidates for surgery to remove or disconnect the brain region triggering the seizures, or for devices that deliver electrical stimulation to the brain or a major nerve in the neck to interrupt seizure activity.
Migraine and Headache Disorders
Migraine is far more than a bad headache. It is a complex neurological disorder rooted in the trigeminovascular system, a network of nerve fibers that surrounds blood vessels in the brain’s protective membranes. When this system is activated, it releases signaling molecules, most prominently a peptide called CGRP, from nerve endings around those blood vessels. That release kicks off a chain of events including local inflammation, blood vessel dilation, and sensitization of pain-sensing nerves.20PubMed Central. CGRP and the Trigeminal System in Migraine The sensitization can spread centrally, which is why a migraine that starts as a throbbing on one side of the head can eventually make even light touch on the scalp feel painful.
Understanding CGRP’s role transformed migraine treatment. A new class of preventive medications, monoclonal antibodies that block CGRP or its receptor, emerged directly from decades of research on the trigeminovascular system.21PubMed Central. Migraine and the trigeminovascular system-40 years and counting Blocking the vessel-dilating and nerve-sensitizing signals effectively prevents attacks in many patients, reinforcing the importance of these peripheral vascular mechanisms.22PubMed Central. The vessel-to-neuron trigeminovascular hypothesis of migraine pathogenesis – the ‘pro’ argument For patients who lived through the era when migraine was dismissed as “just a headache” or a stress problem, these biologically targeted therapies represent a genuine shift.
Neuromuscular Conditions
Neuromuscular disorders affect the connection between nerves and muscles. Myasthenia gravis is a classic example: the immune system produces antibodies that attack receptors at the junction where nerve signals cross to muscle fibers, causing fluctuating muscle weakness that worsens with use.23The Journal of Immunology. Suppression of acetylcholine receptor endocytosis in neuromuscular junction by carbonic anhydrase III in the pathogenesis of myasthenia gravis Treatment typically involves medications that boost the remaining nerve signals, immunosuppressive drugs to reduce antibody production, and sometimes surgical removal of the thymus gland.
Amyotrophic lateral sclerosis, or ALS, sits at the more devastating end of the neuromuscular spectrum. It involves progressive death of the motor neurons that control voluntary movement. Research suggests that the neuromuscular junction may be an early site of trouble in ALS, with evidence pointing to shared immunological mechanisms between ALS and myasthenia gravis.24PubMed. Myasthenia gravis and amyotrophic lateral sclerosis: A pathogenic overlap Despite this, ALS remains extremely difficult to treat. Current therapies offer modest slowing of progression at best, making it one of the most active areas of neurological research.
Pediatric Neurology
Children present their own set of neurological challenges. Conditions like cerebral palsy, epilepsy, autism spectrum disorder, and a wide range of neurodevelopmental disorders fall under the care of child neurologists. Diagnosing cerebral palsy has grown more complex as genetic testing reveals that some children previously given a cerebral palsy diagnosis actually have treatable genetic movement disorders.25PubMed Central. Role of child neurologists and neurodevelopmentalists in the diagnosis of cerebral palsy: A survey study Getting the diagnosis right matters enormously because treatment differs.
Whole genome sequencing is becoming a powerful tool in pediatric neurology. In one study of children with neurodevelopmental disorders, sequencing provided a genetic diagnosis in about a third of cases, with many of the identified variants being entirely new to science.26PubMed. Genetic Diagnosis of Children With Neurodevelopmental Disorders Using Whole Genome Sequencing That diagnostic yield is high enough to change clinical practice: for a family that has spent years without answers, identifying the exact genetic cause can end a diagnostic odyssey and sometimes open doors to targeted treatment.
Gene Therapy and Emerging Treatments
Gene therapy represents one of the most promising frontiers in neurology. The basic idea is to deliver functional copies of a gene, or genetic instructions that correct a disease mechanism, directly into nerve cells. This approach has already reached clinical use for rare genetic disorders like spinal muscular atrophy, where a single treatment can dramatically change outcomes for infants who would otherwise face severe disability or death.27PubMed Central. Progress in gene therapy for neurological disorders
The field is expanding beyond rare diseases. Clinical trials are testing gene therapy approaches for Parkinson’s disease, and treatments for drug-resistant epilepsy have been moving toward first-in-human trials.28PubMed. Gene Therapy for Neurological Disease: State of the Art and Opportunities for Next-generation Approaches The challenges remain substantial, particularly getting genetic material past the blood-brain barrier and into the right cells, but the pace of progress has accelerated. For common non-genetic conditions, gene therapy strategies aim not to replace a faulty gene but to deliver therapeutic proteins or modify circuits, a conceptually different approach that broadens the potential patient population considerably.
The Global Burden of Neurological Disease
The scale of neurological illness worldwide is staggering. A systematic analysis covering 1990 through 2021 found that 37 neurological conditions collectively accounted for about 443 million disability-adjusted life-years globally, making them the leading group cause of lost health.29The Lancet. Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Those numbers increased by about 18% over that thirty-year period, driven by population growth and aging. Neurological disorders are also the second leading cause of death worldwide, and the burden falls disproportionately on low- and middle-income countries, where access to neurologists, imaging equipment, and advanced therapies is limited.30PubMed Central. The global burden of neurological disorders: translating evidence into policy
Sleep Disorders and Nutritional Neurology
Not every neurological condition fits neatly into the categories above. Sleep medicine is a growing subspecialty within neurology. Conditions like narcolepsy and REM sleep behavior disorder arise from dysfunction in the specific brain circuits that control transitions between wakefulness and sleep stages.31PubMed. Brain Circuitry Controlling Sleep and Wakefulness REM sleep behavior disorder, in which people physically act out their dreams, has attracted particular attention because it is strongly linked to later development of Parkinson’s disease and related neurodegenerative conditions, sometimes by a decade or more.
Nutritional deficiencies can also cause neurological damage that mimics other diseases. Vitamin B12 deficiency, for example, disrupts the normal production of myelin, the same insulating coating damaged in multiple sclerosis, and interferes with neurotransmitter production. The result can range from numbness and tingling in the hands and feet to memory problems and mood changes.32PubMed Central. Neuropsychiatric Disorders Associated With Vitamin B12 Deficiency: An Autobiographical Case Report Unlike most neurodegenerative diseases, B12 deficiency is reversible when caught early, which makes it one of the conditions neurologists are most keen not to miss.